Richwood Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$643K Sell
10,597
-410
-4% -$23.9K 0.5% 48
2025
Q4
$682K Sell
11,007
-880
-7% -$42.3K 0.49% 47
2025
Q3
$536K Sell
11,887
-1,416
-11% -$66.1K 0.42% 54
2025
Q2
$616K Buy
13,303
+225
+2% +$11K 0.51% 47
2025
Q1
$798K Buy
13,078
+730
+6% +$42.6K 0.68% 36
2024
Q4
$698K Buy
12,348
+750
+6% +$41.9K 0.58% 39
2024
Q3
$600K Sell
11,598
-719
-6% -$33.7K 0.5% 51
2024
Q2
$512K Sell
12,317
-504
-4% -$22.6K 0.45% 56
2024
Q1
$695K Sell
12,821
-1,949
-13% -$99.3K 0.62% 41
2023
Q4
$758K Sell
14,770
-486
-3% -$25.5K 0.71% 33
2023
Q3
$885K Sell
15,256
-135
-0.9% -$8.27K 0.9% 26
2023
Q2
$984K Sell
15,391
-49
-0.3% -$3.29K 0.96% 23
2023
Q1
$1.07M Sell
15,440
-21
-0.1% -$1.48K 1.07% 22
2022
Q4
$1.11M Buy
15,461
+206
+1% +$15.5K 1.12% 22
2022
Q3
$1.08M Sell
15,255
-90
-0.6% -$6.53K 1.19% 18
2022
Q2
$1.18M Buy
15,345
+82
+0.5% +$6.25K 1.19% 17
2022
Q1
$1.11M Buy
15,263
+70
+0.5% +$4.7K 1% 22
2021
Q4
$947K Buy
+15,193
New +$891K 0.83% 26

Other funds holding BMY

Richwood Investment Advisors's BMY Position: Q1 2026 in Review

Richwood Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q1 2026, selling an estimated $23.9K and leaving 10,597 shares worth $643K. The position accounts for 0.5% of the portfolio, ranked #48.

Richwood Investment Advisors first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.18M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Richwood Investment Advisors held 10,597 shares of Bristol-Myers Squibb worth $643K as of Q1 2026.
  • Richwood Investment Advisors sold 410 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.9K.
  • Bristol-Myers Squibb made up 0.5% of Richwood Investment Advisors's portfolio in Q1 2026, its #48 holding.
  • Richwood Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • Richwood Investment Advisors's Bristol-Myers Squibb position peaked at $1.18M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Richwood Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.